Evans, W. S., Anderson, S. M., Hull, L. T., Azimi, P. P., Bowers, C. Y., & Veldhuis, J. D. (2001). Continuous 24-hour intravenous infusion of recombinant human growth hormone (GH)-releasing hormone-(1-44)-amide augments pulsatile, entropic, and daily rhythmic GH secretion in postmenopausal women equally in the estrogen-withdrawn and estrogen-supplemented states. The journal of clinical endocrinology and metabolism, 86(2), 700. https://doi.org/10.1210/jc.86.2.700
Citácia podle Chicago (17th ed.)Evans, W S., S M. Anderson, L T. Hull, P P. Azimi, C Y. Bowers, a J D. Veldhuis. "Continuous 24-hour Intravenous Infusion of Recombinant Human Growth Hormone (GH)-releasing Hormone-(1-44)-amide Augments Pulsatile, Entropic, and Daily Rhythmic GH Secretion in Postmenopausal Women Equally in the Estrogen-withdrawn and Estrogen-supplemented States." The Journal of Clinical Endocrinology and Metabolism 86, no. 2 (2001): 700. https://doi.org/10.1210/jc.86.2.700.
Citácia podľa MLA (8th ed.)Evans, W S., et al. "Continuous 24-hour Intravenous Infusion of Recombinant Human Growth Hormone (GH)-releasing Hormone-(1-44)-amide Augments Pulsatile, Entropic, and Daily Rhythmic GH Secretion in Postmenopausal Women Equally in the Estrogen-withdrawn and Estrogen-supplemented States." The Journal of Clinical Endocrinology and Metabolism, vol. 86, no. 2, 2001, p. 700, https://doi.org/10.1210/jc.86.2.700.